Two Reports and a Profile on Sekur Private Private Data (SWISF).
RELATED: Sekur Private Data Ltd.'s SekurVPN Swiss Hosted, Privacy VPN Records Sales up over 100% Month-Over-Month
| FUNDAMENTAL RESEARCH |
PRICE TARGET $0.68* | 264%...
SekurMessenger vs. the WhatsApp Messenger.
Can the World’s Most Secure Text Messenger and Email Provider Challenge the Industry Leader WhatsApp?
Can A Tiny Swiss Provider of Private and Secure Text...
Hapbee’s (HAPB) Revolutionary Sleep Aid, Lands on the Shelves of Target Stores.
When we first came across Hapbee (HAPB) we described it as having a medical technology (a device) that had the "highest potential over any...
Is Citius Pharma a Ten Bagger?
As is From $0.80 to $8.00..
One of our favorite Broker/Dealer Analysts thinks it is..
Positive news today from an old favorite Citius Pharma (CTXR),...
Our 10 Top Turnaround Situations Under $5.00.
Can These Stocks Double in Value, and Still be 70% off Their Recent High?
Read More and Decide.
Point #1. We've been playing turnaround situations...
Bridging the Immunity Gap: An In-Depth Conversation with GeoVax’s (GOVX) CEO, David Dodd
In an era of rapid scientific development, the pharmaceutical industry constantly evolves to meet new challenges and seize emerging opportunities. GeoVax, a biotechnology company...
Tsunami of Business Headed Pressure Bio’s (PBIO) Way?
We think there is a potential Tsunami of business headed towards Pressure Bio over then next 3-5 years. And well beyond.
As the chart...
Report: Is Psycheceutical BioScience (BWVI) One of the Most Important Companies in the Psychedelic...
Initiating Coverage on Psycheceutical BioScience (BWVI).
"Imagine Applying a Psychedelic Topically, Receiving the Benefits Quicker Than Alternative Delivery Methods (Injection, Intravenously, Nasally or Orally) and...
Is Ultra-Shear’s™ Nano-THC the Most Powerful and Fast-Acting THC in the World?
We Think it is!
Webinar to discuss effectiveness.
The Company does not make CBD Oil, it makes any CBD Oil better.
Press release out today about their...
Hepion Pharmaceuticals (HEPA) Announces Passing of Key Safety Milestone in Phase 2b ‘ASCEND-NASH’ Trial...
Completion of Enrollment Remains on Track for Q1, 2024
"While we recently had fireworks, we could be looking at real fireworks in the coming year....















